Abstract B002: A first-in-human, first-in-class, phase 1 trial of QEQ278 in patients with advanced solid tumors
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Christophe Le Tourneau, Martin Schuler, Massimo A. Di Nicola, Yick Ching Justina Lam, Yasutoshi Kuboki, Chia-Chi Lin, Jean-Pascal Machiels, Justin F. Gainor, Zev A. Wainberg, Manish R. Patel, Javier A. Otero, Kimberly Ann. Kornbluth, Rebhi Bsharat, Jaya Pisupati, Thiruvamoor Ramkumar, Anwesha Chaudhury, Arjun Oberoi
Institutions: Institut Curie, Essen University Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori, National Cancer Centre Singapore, National Cancer Center Hospital East, National Taiwan University Hospital, Cliniques Universitaires Saint-Luc, UCLouvain, Massachusetts General Hospital, University of California, Los Angeles, Novartis (United States), Novartis (Switzerland), Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444779
Cites:
Cited by:
Related to: